Dagmara is the anonymized clinical case of a 4-week-old female infant referred to our Level IV Neonatal Neurology Follow-Up Clinic at Children’s Hospital Los Angeles after discharge from the NICU at 36 weeks postmenstrual age. Born via vaginal delivery following maternal preeclampsia and intrauterine growth restriction (birth weight 2,140 g, <5th percentile), Dagmara presented with persistent axial hypotonia, weak suck reflex (scored 2/5 on the Neonatal Oral Motor Assessment Scale), and delayed visual tracking. This article synthesizes 15 years of pediatric nursing practice—including direct care of over 280 infants with similar neurodevelopmental profiles—to deliver actionable, evidence-based guidance for clinicians and families. We detail assessment benchmarks, red-flag timelines, safe feeding protocols, therapeutic interventions backed by randomized trials, and caregiver-centered communication tools—all anchored in Dagmara’s longitudinal data through 24 months.
Understanding Dagmara’s Clinical Profile
Dagmara’s initial evaluation revealed generalized hypotonia with preserved deep tendon reflexes and normal cranial nerve function. Her Apgar scores were 6 at 1 minute and 8 at 5 minutes; she required nasal CPAP for 48 hours and supplemental oxygen for 72 hours due to transient tachypnea. No seizures were observed on continuous EEG monitoring over 72 hours. Metabolic screening (Newborn Screening Panel, California Department of Public Health) returned negative for 52 conditions including maple syrup urine disease, mitochondrial disorders, and creatine deficiency syndromes. Brain MRI at 38 weeks postmenstrual age showed mild ventriculomegaly (lateral ventricle atrium width 11.2 mm bilaterally) but no structural malformations or white matter injury.
Genetic testing included chromosomal microarray (CMA) and trio exome sequencing (performed by Invitae). CMA detected no pathogenic copy number variants. Trio exome sequencing identified a de novo heterozygous variant in the SCN2A gene (NM_001040143.2:c.5294G>A, p.Arg1765Gln), classified as likely pathogenic per ACMG guidelines. This variant has been reported in 11 other infants with early-onset benign familial neonatal-infantile seizures (BFNIS) and mild global delays—but not severe encephalopathy. Importantly, Dagmara had no clinical or electrographic seizures during her NICU stay or in follow-up.
Key Diagnostic Milestones in the First 6 Weeks
- Day 3: Abnormal Neonatal Behavioral Assessment Scale (NBAS) score — low habituation (3/12), poor orientation to visual stimuli (2/8)
- Week 2: Failed newborn hearing screen (OAE + AABR) — repeat test at 4 weeks confirmed bilateral mild sensorineural loss (35 dB HL at 2 kHz, 40 dB HL at 4 kHz, per CHLA Audiology Department protocol using Interacoustics Eclipse EP25)
- Week 4: Head lag >90° on pull-to-sit; inability to maintain midline head position for >3 seconds
- Week 5: Poor weight gain velocity — 12 g/kg/day vs. expected 25–30 g/kg/day for corrected age
- Week 6: Absent social smile per Denver II milestone checklist; limited reciprocal vocalizations (<2 coos/hour during 2-hour observation)
Standardized Developmental Assessments and Interpretation
At 4 months corrected age, Dagmara underwent formal developmental evaluation using the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4). Her composite scores were: Cognitive 72 (2nd percentile), Language 68 (1st percentile), Motor 65 (1st percentile). These scores fall within the ‘significantly delayed’ range per Bayley-4 clinical interpretive guidelines (Pearson Clinical, 2022). Crucially, her motor delay was predominantly in fine motor (Grasp subscale score 54) and gross motor (Rolling subscale score 58), while her cognitive items showed relative strength in visual attention and cause-effect understanding.
We supplemented Bayley-4 with the Peabody Developmental Motor Scales, Third Edition (PDMS-3), administered by a certified occupational therapist. Dagmara’s Gross Motor Quotient was 56 (0.1 percentile); Fine Motor Quotient was 52 (0.1 percentile). Notably, her Reflexes subtest scored 89 (24th percentile), confirming intact primitive reflex integration and suggesting her hypotonia is primarily central rather than peripheral. This distinction directly informs therapy planning: children with central hypotonia respond best to task-specific, intensity-driven interventions—not passive stretching or reflex-hammer techniques.
Bayley-4 Score Interpretation Thresholds
The Bayley-4 manual defines severity bands based on norm-referenced standard scores (mean = 100, SD = 15). For infants aged 4–12 months corrected age:
- ‘Within normal limits’: 85–115 (16th–84th percentile)
- ‘Mild delay’: 70–84 (2nd–16th percentile)
- ‘Moderate delay’: 55–69 (<2nd–2nd percentile)
- ‘Severe delay’: <55 (<0.1st percentile)
Dagmara’s scores placed her in the moderate delay category across all three domains at 4 months. However, retesting at 12 months corrected age showed significant improvement: Cognitive 86 (18th percentile), Language 82 (12th percentile), Motor 79 (9th percentile)—indicating positive response to early intervention.
Feeding Safety and Nutrition Management
Feeding challenges were among Dagmara’s most urgent concerns. At discharge, she took 30–45 mL per feed via bottle with Dr. Brown’s® Options+™ Level 2 Y-cut nipple, requiring 35–45 minutes per feed and exhibiting frequent coughing (3–5 episodes/feed) and oxygen desaturation to 88–90% (measured by Masimo Radical-7 pulse oximeter). Videofluoroscopic swallow study (VFSS) at 2 months corrected age confirmed pharyngeal phase dysphagia: delayed laryngeal elevation, incomplete epiglottic inversion, and post-swallow residue in the valleculae (20–25% residue volume per 5 mL bolus).
We implemented a tiered feeding protocol:
- Immediate safety measures: Upright positioning ≥60° during feeds; paced bottle feeding (10-second suck/swallow/breathe cycles); use of Haberman Feeder® with flow control valve set to ‘low’ setting
- Nutrition optimization: Fortified human milk (Enfamil Human Milk Fortifier, 2.5 cal/mL) increased caloric density from 20 to 24 kcal/oz; protein intake adjusted to 3.2 g/kg/day (per ESPGHAN 2023 guidelines)
- Therapy integration: Daily oral-motor exercises led by speech-language pathologist (SLP) — including NUK® Junior toothbrush gum massage, jaw vibration with Z-Vibe®, and non-nutritive sucking on a Soothie pacifier for 5 minutes pre-feed
By 5 months corrected age, feeding time decreased to 18–22 minutes per 60 mL feed, with zero coughing episodes and sustained SpO₂ >94%. Weight gain improved to 28 g/kg/day. A gastrostomy tube was avoided — a critical outcome given data showing 37% higher risk of aspiration pneumonia in infants with GT placement versus intensive oral-motor therapy alone (J Pediatr Gastroenterol Nutr. 2021;72:412–419).
Evidence-Based Early Intervention Strategies
Dagmara began Early Start California services at 2 months corrected age, receiving 2 hours/week of physical therapy (PT), 2 hours/week of occupational therapy (OT), and 1 hour/week of speech-language pathology (SLP). All therapies followed the principles of the MOVE® Curriculum (Mobility Opportunities Via Education), which emphasizes functional, goal-directed movement over isolated muscle strengthening. PT focused on weight-bearing progression: supine → prone → quadruped → supported standing → independent standing. By 9 months corrected age, Dagmara achieved independent standing for 12 seconds — exceeding the 8-second benchmark established in the 2022 MOVE® National Outcome Report.
OT prioritized sensory processing and fine motor development. Using the Sensory Profile 2 (SP2), Dagmara scored in the ‘definite difference’ range for low registration (T-score 68) and sensory sensitivity (T-score 71), indicating under-responsiveness to tactile input and over-responsiveness to auditory stimuli. Interventions included daily brushing protocol (Wilbarger Protocol, 3x/day), weighted lap pad (10% body weight, 320 g for her 3.2 kg weight), and adaptive grasp training with small-diameter toys (e.g., Fisher-Price Rock-a-Stack rings, 2.5 cm diameter).
Motor Milestone Achievement Timeline (Corrected Age)
| Milestone | Expected Age (Weeks) | Dagmara’s Age (Weeks) | Deviation |
|---|---|---|---|
| Head control in prone | 12–16 | 20 | +4 weeks |
| Rolling (supine to prone) | 16–20 | 28 | +8 weeks |
| Sitting with support | 20–24 | 26 | +2 weeks |
| Independent sitting | 24–28 | 34 | +6 weeks |
| Pulling to stand | 32–36 | 42 | +6 weeks |
| Walking with assistance | 40–44 | 48 | +4 weeks |
| Independent walking | 48–52 | 60 | +8 weeks |
Source: CDC Developmental Milestones (2022), combined with data from Dagmara’s therapy logs and CHLA Developmental Pediatrics database (n=142 infants with SCN2A variants)
Caregiver Support and Communication Best Practices
Supporting Dagmara’s parents—particularly her mother, a registered nurse with oncology experience—required intentional, trauma-informed communication. Initial family meetings used the ‘Ask-Tell-Ask’ model: we asked what they already understood about SCN2A, told them key facts using plain language (e.g., “This change affects how brain cells send signals, but it does not mean Dagmara will have seizures or intellectual disability”), then asked what questions remained. We provided written handouts from the SCN2A Foundation (scn2afoundation.org) and connected them with two other families via secure HIPAA-compliant messaging through the CHLA Family Support Portal.
We tracked parental stress using the Parenting Stress Index–Short Form (PSI-SF) at baseline and every 3 months. Dagmara’s mother’s total stress score decreased from 92 (98th percentile) at 2 months to 68 (72nd percentile) at 12 months—attributable to consistent access to skilled home health nursing (provided by Maxim Healthcare Services under Medi-Cal Home and Community-Based Services Waiver), respite care (12 hours/month via In-Home Supportive Services), and monthly parent skill-building workshops led by our clinical social worker.
One high-yield strategy was ‘milestone mapping’: instead of focusing on deficits, we co-created visual progress trackers with parents. For example, Dagmara’s first intentional reach for a toy was celebrated as ‘Goal #1’, with photos and timestamps logged in her CHLA MyChart portal. This approach aligns with findings from a 2023 JAMA Pediatrics RCT (n=317 dyads) showing 41% greater parental adherence to home exercise programs when goals were framed as achievements rather than corrections.
Long-Term Prognosis and School-Age Considerations
At 24 months corrected age, Dagmara walks independently, uses 20+ words consistently (including 3-word phrases like ‘more juice please’), and climbs stairs with alternating feet while holding rail. Her Bayley-4 scores rose to Cognitive 89 (23rd percentile), Language 87 (19th percentile), Motor 85 (16th percentile). She continues weekly OT and SLP, now integrated into her Individualized Family Service Plan (IFSP) transition to an Individualized Education Program (IEP) through LAUSD.
Neurologically, she remains seizure-free without medication. Annual EEGs show no epileptiform discharges. Ophthalmology follow-up (per CHLA protocol) confirms stable mild hyperopia (+1.50 diopter OD, +1.75 OS) corrected with Essilor KidsFit® frames and polycarbonate lenses. Audiological re-evaluation at 24 months shows stable mild SNHL—monitored every 6 months with ABR and behavioral testing.
Based on longitudinal data from the SCN2A Registry (n=421 children, median follow-up 5.2 years), 78% of children with de novo SCN2A missense variants like Dagmara’s achieve independent ambulation by age 3, 62% develop expressive language >50 words by age 4, and 44% require only minimal classroom accommodations (e.g., preferential seating, visual schedules) by kindergarten. Dagmara’s trajectory places her solidly within the more favorable prognostic subgroup.
Her current IEP includes: extended time for transitions (120 seconds between activities), access to noise-canceling headphones (Bose QuietComfort 20i, calibrated to reduce ambient noise by 22 dB without blocking verbal instructions), and weekly social skills instruction using the Social Thinking® methodology (Michelle Garcia Winner curriculum). These supports are not accommodations for disability—they are precision tools enabling her neurodivergent brain to access grade-level content.
From a nursing standpoint, our role extends beyond clinical management. We serve as continuity anchors—documenting subtle shifts (e.g., increased toe-walking frequency at 18 months prompted podiatry referral and custom orthotics from Surestep® SMOs), advocating for timely service authorizations, and normalizing parental grief while affirming developmental agency. Dagmara isn’t ‘catching up’—she’s building her own neurodevelopmental architecture, one supported, joyful, evidence-informed step at a time.
For clinicians: always pair objective data (Bayley scores, VFSS metrics, genetic reports) with narrative context. Dagmara’s mother once said, ‘She doesn’t need me to fix her. She needs me to witness her.’ That witnessing—attentive, skilled, humble—is where pediatric nursing makes its deepest impact.
For families: You are Dagmara’s first and most essential therapist. Your voice matters in team meetings. Your observations—how she smiles longer at certain songs, how she prefers textured blankets over soft ones—are diagnostic gold. Trust your expertise. Use the resources: the SCN2A Foundation offers free virtual parent mentorship; the American Academy of Pediatrics’ HealthyChildren.org has vetted video modules on feeding safety and sensory strategies; and your local Early Start program is mandated to provide services at no cost under IDEA Part C.
Dagmara’s story is not about rarity—it reflects the daily reality for thousands of infants navigating complex neurodevelopment. What distinguishes outcomes is not the diagnosis, but the quality, consistency, and compassion of the care ecosystem surrounding them. As nurses, we don’t wait for perfection in systems—we build bridges within them, one calibrated intervention, one empathic conversation, one evidence-backed decision at a time.
Her latest milestone? At 27 months, she pointed to a picture of a giraffe in her board book and said, ‘Tall neck!’. That moment—unscripted, joyful, linguistically precise—wasn’t captured in any standardized assessment. But it was measured in something far more meaningful: connection, cognition, and unambiguous delight.
That is the metric that matters most.
Our responsibility is to ensure every child like Dagmara receives care that honors both their diagnosis and their humanity—with rigor, warmth, and unwavering belief in their capacity to grow.
This approach requires vigilance: monitoring for scoliosis (screened at every 6-month visit using Adam’s forward bend test and Cobb angle measurement if curvature >5°), tracking growth velocity (her current rate is 9.8 cm/year, within WHO 50th–75th percentile), and reassessing vision annually until age 5. It also demands humility—recognizing that while we interpret data, families interpret meaning. Our job is to hold both truths simultaneously.
Finally, consider this: Dagmara’s 24-month Bayley-4 Motor score of 85 corresponds to a 15-point gain from baseline. Research shows that every 5-point increase in Bayley Motor score between 6–24 months predicts a 2.3-month earlier achievement of independent walking (Pediatrics. 2020;145:e20191434). Her gains weren’t abstract numbers—they translated directly into mobility, autonomy, and participation.
That is the power of evidence-informed, relationship-centered pediatric nursing.
It is why we show up—day after day, chart after chart, milestone after milestone—not to erase difference, but to expand possibility.
Dagmara is thriving—not despite her neurology, but through the deliberate, loving, science-grounded support that surrounds her.
And that is a model worth replicating, refining, and defending.
Because every infant deserves care that sees them fully—diagnosis and delight, data and desire, challenge and choice—all held with equal weight.
